Literature DB >> 20068123

Remission of persistent methamphetamine-induced psychosis after electroconvulsive therapy: presentation of a case and review of the literature.

David J Grelotti1, Gen Kanayama, Harrison G Pope.   

Abstract

Illicit methamphetamine abuse represents a major problem in many countries worldwide, including the United States. Prolonged regular smoking or injection of methamphetamine can cause a psychosis, typically characterized by paranoid delusions and auditory hallucinations and often associated with disturbances in mood. These symptoms may persist long after methamphetamine is discontinued and may prove refractory to antipsychotic medications. The authors describe a patient who developed a typical methamphetamine psychosis that persisted despite months of abstinence from methamphetamine and weeks of treatment with antipsychotic medication but that responded promptly to electroconvulsive therapy (ECT) on two separate occasions: on initial presentation and again a year later when the patient relapsed into methamphetamine abuse and developed psychosis again. The authors review the large international literature on methamphetamine psychosis, much of which is from Japan and has not previously been summarized in English. Persistent methamphetamine psychosis has been widely reported in Japan for more than 50 years but is rarely discussed in the American literature, possibly because some such cases are misdiagnosed in the United States as primary psychotic disorders. Given the growing public health problem of methamphetamine abuse in the United States, the distinction between persistent methamphetamine psychosis and a primary psychotic disorder has grown increasingly important. Thus, American clinicians should be alert to the possibility of methamphetamine psychosis and may wish to consider ECT in refractory cases.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20068123     DOI: 10.1176/appi.ajp.2009.08111695

Source DB:  PubMed          Journal:  Am J Psychiatry        ISSN: 0002-953X            Impact factor:   18.112


  23 in total

1.  Culture, psychosomatics and substance abuse: the example of body image drugs.

Authors:  Gen Kanayama; James I Hudson; Harrison G Pope
Journal:  Psychother Psychosom       Date:  2012-01-18       Impact factor: 17.659

2.  Residential eviction predicts initiation of or relapse into crystal methamphetamine use among people who inject drugs: a prospective cohort study.

Authors:  William Damon; Ryan McNeil; M-J Milloy; Ekaterina Nosova; Thomas Kerr; Kanna Hayashi
Journal:  J Public Health (Oxf)       Date:  2019-03-01       Impact factor: 2.341

3.  Comparison of intranasal methamphetamine and d-amphetamine self-administration by humans.

Authors:  Matthew G Kirkpatrick; Erik W Gunderson; Chris-Ellyn Johanson; Frances R Levin; Richard W Foltin; Carl L Hart
Journal:  Addiction       Date:  2012-04       Impact factor: 6.526

4.  Cannabinoid receptors mediate methamphetamine induction of high frequency gamma oscillations in the nucleus accumbens.

Authors:  Joshua T Morra; Stanley D Glick; Joseph F Cheer
Journal:  Neuropharmacology       Date:  2012-05-15       Impact factor: 5.250

5.  Sex Differences in Methamphetamine Use and Dependence in a Thai Treatment Center.

Authors:  Teerayuth Rungnirundorn; Viroj Verachai; Joel Gelernter; Robert T Malison; Rasmon Kalayasiri
Journal:  J Addict Med       Date:  2017 Jan/Feb       Impact factor: 3.702

6.  A direct comparison of the behavioral and physiological effects of methamphetamine and 3,4-methylenedioxymethamphetamine (MDMA) in humans.

Authors:  Matthew G Kirkpatrick; Erik W Gunderson; Audrey Y Perez; Margaret Haney; Richard W Foltin; Carl L Hart
Journal:  Psychopharmacology (Berl)       Date:  2011-06-30       Impact factor: 4.530

Review 7.  Is cognitive functioning impaired in methamphetamine users? A critical review.

Authors:  Carl L Hart; Caroline B Marvin; Rae Silver; Edward E Smith
Journal:  Neuropsychopharmacology       Date:  2011-11-16       Impact factor: 7.853

Review 8.  Methamphetamine psychosis: epidemiology and management.

Authors:  Suzette Glasner-Edwards; Larissa J Mooney
Journal:  CNS Drugs       Date:  2014-12       Impact factor: 5.749

9.  Evidence for shared genetic risk between methamphetamine-induced psychosis and schizophrenia.

Authors:  Masashi Ikeda; Yuko Okahisa; Branko Aleksic; Mujun Won; Naoki Kondo; Nobuya Naruse; Kumi Aoyama-Uehara; Ichiro Sora; Masaomi Iyo; Ryota Hashimoto; Yoshiya Kawamura; Nao Nishida; Taku Miyagawa; Masatoshi Takeda; Tsukasa Sasaki; Katsushi Tokunaga; Norio Ozaki; Hiroshi Ujike; Nakao Iwata
Journal:  Neuropsychopharmacology       Date:  2013-04-12       Impact factor: 7.853

10.  Predictors of methamphetamine psychosis: history of ADHD-relevant childhood behaviors and drug exposure.

Authors:  Ruth Salo; Catherine Fassbender; Ana-Maria Iosif; Stefan Ursu; Martin H Leamon; Cameron Carter
Journal:  Psychiatry Res       Date:  2013-07-26       Impact factor: 3.222

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.